Idrasil, a full-spectrum cannabinoid pill, satisfies the medical community with its standardized 25 mg tablet and changes the way patients and physicians view medical marijuana. (PRWeb May 19, 2012) Read the full story at http://www.prweb.com/releases/-medical-marijuana/-information-san-francisc/prweb9525356.htm

Members of Lyme Research Alliance from top left, Executive Director Peter Wild and Greenwich residents, co-founders and executive committee members (from left) Fran Herzog, Debbie Siciliano and Diane Blanchard place their new logo on a wall in their Stamford office recently.

To The Editor: